Therapy for Off Periods in Parkinson’s Shows Efficacy in Phase 3 Clinical Trial
Acorda Therapeutics reported positive Phase 3 results demonstrating that CVT-301 improved motor function in people with Parkinson’s disease…
Ana holds a PhD in immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. Ana was awarded two FCT fellowships and has won the Portuguese Immunology Society Best Paper and Best Poster award in 2009 and 2010, as well as the CESPU International Research Award in 2010. After leaving the lab to pursue a career in science communication, she served as the director of science communication at iMM Lisbon.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Acorda Therapeutics reported positive Phase 3 results demonstrating that CVT-301 improved motor function in people with Parkinson’s disease…
Parkinson’s disease patients now have two additional Centers of Excellence at their service: the NewYork-Presbyterian/Columbia University Medical Center in…
Yoga has been shown to increase flexibility and posture, ease stiffness, and improve balance through the strengthening of core muscles…
A hand-grip test is one of the best measures of muscle decline in Parkinson’s disease, research indicates. Two University…
The first patient has been dosed in a two-part Phase 1 clinical trial evaluating KM-819, Kainos Medicine’s potential disease-modifying…
It’s widely recognized that falling poses a significant risk for people with Parkinson’s disease (PD), but most scientists thought patients…
MYOLYN has asked the U.S. Food and Drug Administration (FDA) for a patent for the functional electrical stimulation (FES)…
The European Union Joint Programme — Neurodegenerative Disease Research (JPND) has launched a call for proposals for “multinational…
Genervon Biopharmaceuticals has published a previously confidential list of Parkinson’s disease-associated (PD) genes it says are controlled by GM6, its…
Vitamin B3 (niacin) was found to boost levels of a compound called NAD that generates energy and repairs DNA, according…
Get regular updates to your inbox.